You searched for "PDS"

110 results found

Business recovery and relaunch: how to grow your patient base in the new economy

As the unprecedented impact of the COVID-19 pandemic continues to be felt, many aesthetic practitioners are facing an uncertain future. In this invaluable article Pam Underdown provides expert advice on how to survive and grow stronger than ever. The global...

Essentials of Plastic Surgery: Q&A Companion

This excellent second edition of Q&A Companion of the very well-established Essentials of Plastic Surgery by Dr Jeffrey Janis provides a complete and detailed overview of the entire plastic surgery syllabus. All material is up-to-date and has been written as...

How I Do It - Approaches to acne treatment: Pulsed-dye laser

Acne vulgaris is the most common skin disease worldwide and inflammatory acne has significant psychological impact with potential for long-term emotional and physical sequelae [1]. Energy based treatments are useful both as adjuncts to traditional therapies and particularly for patients...

The International Society of Aesthetic Plastic Surgery ISAPS Releases Statistics on Cosmetic Procedures Worldwide

There is a whole range of interesting statistics produced by the ISAPS latest survey. It provides a breakdown of the 23 million cosmetic procedures that were carried out worldwide in 2013 both by country and type of procedure. Look at...

Intraline KOL appointment

Intraline Medical Aesthetics is thrilled to announce the appointment of aesthetic doctors, Dr. Simon Zokaie and Dr. Mark Holmes, as Key Opinion Leaders for the Intraline portfolio of medical aesthetic products.

Cutera Redefines the Muscle Sculpting Market with US Commercial Launch of truSculpt® flex

CUTERA, INC., a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, announced today the U.S. limited commercial launch of truSculpt® flex, the Company’s new muscle sculpting platform.

Recurrent corneal erosions secondary to isotretinoin use

This article originally appeared in Eye News Dec/Jan 2021 Isotretinoin (13–cis-retinoic acid) is the first line treatment for moderate to severe nodulocystic or papulopustular acne [1,2]. Although it is a safe medication, it has several adverse side-effects, including ophthalmic manifestations,...

Non-surgical management of actinic keratosis, Bowen’s disease and non-melanoma skin cancer

Non-melanoma skin cancers (NMSCs) are primary cutaneous neoplasms comprising mainly of basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs). In 2011, 102,628 cases of NMSCs (74% BCC and 23% SCC) were recorded in England, making NMSC the most common...

Croma-Pharma completed the decentralized procedure for its botulinum toxin to treat glabellar (frown) lines

Croma’s botulinum toxin submission in Europe is based on the data of 3 completed randomized, placebo-controlled phase III trials that enrolled a total of >1000 subjects in Europe and the US.

Blepharoplasty and orbital fat repositioning

The authors present their personal technique on lower blepharoplasty with preserving a strong orbicularis oculi sling and maintaining lower eyelid position with periosteal fixation of the lateral canthus and skin- muscle flap. In their technique, after elevation of skin flap,...

Support groups for hidradenitis suppurativa

Hidradenitis suppurativa (HS) is an inflammatory condition characterised by painful inflamed nodules in the apocrine regions of the body. It follows a chronic relapsing clinical course and is a very difficult condition to treat. It has an estimated prevalence of...

What’s new on the horizon for toxins coming to the market?

With the ever increasing demand for injectable treatments, it is important to keep abreast of new developments in the field. International expert Michael Gold reviews the new toxins due to be hitting the market in the next year. We are...